SAN DIEGO & REHOVOT, Israel- Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced two presentations featuring its Bladder EpiCheck® technology at the 35th Annual European Association of Urology (EAU) Virtual Congress.
Go to the inbox of the email
address you just used to sign up.
Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “firstname.lastname@example.org”.
Click on the link inside the <br>email and you’re good to go.